| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |